# Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

> **NCT00510016** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 80 (actual)

## Conditions studied

- Neonatal Abstinence Syndrome

## Interventions

- **DRUG:** Clonidine HCL

## Key facts

- **NCT ID:** NCT00510016
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510016, "Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00510016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*